2008 Midyear Clinical Meeting
Click here to go to the previous page
Debates in Therapeutics 2008
Track:
Educational Sessions
Program Code: 224-L01
Date: Tuesday, December 9, 2008
Time: 8:00 AM to 11:00 AM EST
Location:
W311A
MEETING PLANNING ASSOCIATE:
Dr. Melinda Neuhauser, PharmD
PRESENTER(S):
Vanthida Huang, Assistant Professor, Mercer University College of Pharmacy and Health Sciences
|
Dr. Kays received his Bachelor of Science degree in Pharmacy from the Saint Louis College of Pharmacy in 1985 and his Doctor of Pharmacy degree from the Medical University of South Carolina in 1988. His post-doctoral training includes completion of a one-year residency (1988-1989) and a two-year fellowship (1989-1991) in Infectious Diseases Pharmacotherapy at the Medical University of South Carolina. Following his fellowship, Dr. Kays joined the faculty as an Assistant Professor of Pharmacy Practice in the College of Pharmacy at the Medical University of South Carolina. In May 1998, he joined the faculty at Purdue University School of Pharmacy and Pharmaceutical Sciences, and he was promoted to Associate Professor of Pharmacy Practice with tenure in July 2002.
In addition, Dr. Kays is a Clinical Specialist in Infectious Diseases Pharmacotherapy at Methodist Hospital in Indianapolis. He also holds an adjunct appointment with the Indiana University School of Medicine, where he is Adjunct Associate Professor of Medicine.
Dr. Kays’ research interests include pharmacokinetics and pharmacodynamics of antimicrobial agents and bacterial resistance in gram-positive and gram-negative microorganisms. He has authored or co-authored over 30 original research publications and 5 book chapters, and he has presented over 60 abstracts at scientific meetings. Dr. Kays currently serves as an expert reviewer for 5 journals: Pharmacotherapy, Annals of Pharmacotherapy (Editorial Board, Infectious Diseases), Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology and Infectious Diseases, and Clinical Drug Evaluation.
|
Joseph Kuti,
PharmD, Associate Director, Clinical and Economic Studies,
Hartford Hospital
|
Joseph L. Kuti, Pharm.D., received his Bachelor of Science and Doctor of Pharmacy degrees from Rutgers University, College of Pharmacy in Piscataway, New Jersey. While completing his doctorate, he served as a clinical pharmacist for the medical and surgical intensive care units at Robert Wood Johnson University Hospital in New Brunswick, New Jersey. He then completed a postgraduate fellowship in Antibiotic Management and Pharmacoeconomics at Hartford Hospital in Hartford, Connecticut.
Currently, Dr Kuti is Associate Director of Clinical and Economic Studies at the Center for Anti-Infective Research and Development at Hartford Hospital. He also holds an Adjunct Assistant Professor appointment at the University of Connecticut School of Pharmacy in Storrs, Connecticut. He is a member of the American Society for Microbiology, the American College of Clinical Pharmacy, the Society of Infectious Diseases Pharmacists, and the Society of Industry Leaders.
Dr Kuti’s primary area of research includes the pharmacokinetics, pharmacodynamics, pharmacoeconomics, and outcomes of antimicrobial therapy in severe infections. His research has been published in many original research articles, book chapters, and reviews; furthermore, it has led to implementation of numerous clinical programs designed to optimize antibiotic care of hospitalized patients.
|
|
Dr. LaPlante is currently a tenure track Assistant Professor at the University of Rhode Island’s College of Pharmacy and an Adjunct Clinical Assistant Professor of Medicine at the Warren Alpert Medical School of Brown University. She completed her Bachelor of Science degree in Biology (1996) at Canisius College of Buffalo, and a Doctor of Pharmacy (2002) at Wayne State University in Detroit, Michigan. Her Post-Doctorial Fellowship (2004) was completed in infectious diseases/pharmacotherapy at the Anti-infective Research Laboratory, Wayne State University in Detroit, Michigan. Her foremost research expertise is in infectious diseases, specifically in the treatment, virulence inhibition (toxin and biofilm), colonization and control of methicillin-resistant Staphylococcus aureus (MRSA). She also investigates activity of catheter lock solutions against biofilm producing bacteria. Her clinical practice site and her research is conducted at the Veterans Affairs Medical Center in Providence. She is published in peer-reviewed journals such as Antimicrobial Agents and Chemotherapy, Pharmacotherapy, Expert Opinion in Pharmacotherapy, and Diagnostic Microbiology and Infectious Disease and her research has been presented in Denmark, France, Czech Republic and throughout the United States.
Dr. LaPlante also serves the profession by membership, leadership and participation in a number of organizations, and as a reviewer of manuscripts for Antimicrobial Agents and Chemotherapy, The Journal of Antimicrobial Chemotherapy, Pharmacotherapy, and Diagnostic Microbiology and Infectious Diseases. Dr. LaPlante is a member of many professional societies within pharmacy and infectious disease groups and serves as an expert consultant and national speaker for the pharmaceutical industry.
|
Xi Liu-DeRyke
Dr. Melinda Neuhauser, PharmD, Clinical Pharmacy Specialist, Infectious Diseases, VA Pharmacy Benefits Management SHG
Lance Oyen, PharmD, Mayo Clinic Rochester
Dennis Parker, Jr
|
Kyle Weant is a Clinical Specialist in Emergency Medicine and Critical Care at University of Kentucky HealthCare.
|
- Describe the pro and con sides of selected therapeutic issues.
- Discuss why therapeutic controversy may occur.
- Identify four therapeutic areas in which controversy exists.
